Latest News FDA approves GSK’s RSV vaccine for older adults, world’s first shot against virus Published 1 month ago on May 3, 2023 By Lyron Foster The FDA’s approval is a victory for GSK in a race against Pfizer and Moderna to bring a shot that targets respiratory syncytial virus to the market. Related Topics: Up Next The market is looking for the next ‘domino’ to fall, keeping banks under pressure Don't Miss Here’s what the Federal Reserve’s quarter-point interest rate hike means for you Lyron Foster Lyron Foster is a Hawaii based African American Musician, Author, Actor, Blogger, Filmmaker, Philanthropist and Multinational Serial Tech Entrepreneur. Continue Reading You may like Comments
